Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0377819980180060652
Diagnosis and Treatment
1998 Volume.18 No. 6 p.652 ~ p.659
IMPACTS OF ADDED PROGESTOGEN ON BIOCHEMICAL MARKERS OF THE BONE TURNOVER UNDERGOING HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN


Abstract
Purpose To evaluate the impact of added progestogen on biochemical markers of the bone turnover undergoing hormone replacement therapy in the postmenopausal women. Method : There are 71 postmenopausal women who are divided into three groups (Group I, Group II, Group III). Group I(continuous combined) is given conjugated equine estrogen WEE, 0.625mg, day 1-30) plus medroxy-
progesterone acetate (MPA, 2.5mg, day 1-30), Group II(unopposed estrogen) is given conjugated equine estrogen(CEE, 0.625mg, day 1-30) only, Group III(continuous sequence) is given conjugated equine estrogen(CEE, 0. 625mg, day 1-30) plus medroxyprogesterone acetate (MPA, 5mg, day 1-12). And there were measured serum osteocalcin, serum total alkaline phosphatase and urinary deoxypyridinoline excretion before starting hormone replacement therapy and 12 months later. Results : The serum osteocalcin, serum total alkaline phosphatase and urinary deoxypyridinoline excretion significantly decreased after hormone replacement therapy (Group I, II, III). And there was no significance
KEYWORD
FullTexts / Linksout information
Listed journal information